No Data
Teleflex to Present at the BofA Securities 2025 Health Care Conference
The FDA Has Granted 510(k) Clearance Of An Expansion To The Indications For Use Of Teleflex's QuikClot Control+ Hemostatic Device To Include All Grades Of Internal And External Bleeding
Teleflex Receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+ Hemostatic Device
Express News | Teleflex Receives FDA 510(K) Clearance for Expanded Indications of the Quikclot Control+™ Hemostatic Device
Earnings Preview: Teleflex to Report Financial Results Pre-market on May 01
Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting